GastroPlus™ ADMET Predictor™ MedChem Studio™ DDDPlus™ MedChem Designer™ ADMET Design Suite™ Membrane Plus™

Latest Publications

Best of Both Worlds: Combining Pharma Data and State of the Art Modeling Technology to Improve in silico pKa Prediction.
Read More

Predicting drug-drug interactions involving multiple mechanisms using physiologically based pharmacokinetic modeling: A case study with ruxolitinib.
Read More

Simulation of In Vitro Dissolution Behavior Using DDDPlus™.
Read More

Events

February 16-18 - Cambridge Healthtech Molecular Medicine Tri-Conference in San Francisco, CA.
Read More

February 23-27 - GastroPlus™ San Diego Workshop Week in San Diego, CA.
Read More

News

Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical d...
Read More

Simulations Plus Reports First Quarter FY2015 Financial Results
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical d...
Read More